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Editorial on the Research Topic
Circuit Mechanisms of Neurodegenerative Diseases
Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD),
Huntington’s disease (HD), or Amyotrophic lateral sclerosis (ALS) are histopathologically
characterized by the formation of protein aggregates and the selective death of a defined population
of neurons. These diseases have traditionally been viewed as being caused by the selective
dysfunction of those vulnerable neurons via cell autonomous mechanisms. Current evidence,
however, strongly implicates a causal involvement of altered neuronal circuit function in triggering
and perpetuating the degenerative cascade. Recent methodological advances offered by newly
developed genetic tools, in vivo electrophysiology and imaging techniques, enabled the selective
assessment and manipulation of dedicated cell populations and neural circuits in vivo. Such
approaches have provided evidence that circuit alterations result from complex changes at the
level of synapses, intrinsic excitability of cells and disrupted connectivity within local microcircuits
and between projection areas. This ultimately results in altered activity patterns of neurons,
impaired information processing in a disease-stage dependent manner and eventual neuronal
loss. Intriguingly, preclinical studies in rodent models suggest that many of those structural and
functional alterations within a neuronal network are already found at early presymptomatic stages,
long before typical markers of degeneration are detectable. These findings support the notion that
circuit dysfunction is likely not only a consequence of degenerative processes in NDs, but can in
fact represent a main driver of the pathology. This novel concept not only opens up new therapeutic
avenues by shedding light into brain-region, and cell-type specific alterations occurring in a disease-
stage specificmanner; but moreover, it has the potential to identify novel diagnostic approaches and
therapeutic windows.
In this Research Topic Werner et al. summarize the current status and opportunities of
in vivo imaging using miniature fluorescence microscopes (miniscopes), which enables chronic
monitoring of neuronal activity and the disentangling of circuit deficits in NDs. A number
of review articles summarize the current knowledge about the impact of neurodegenerative
processes on neural circuit function and development. As such, Blumenstock and Dudanova
explore cell-type specific impairments in cortical and striatal circuits in HD, while Binda
et al. summarize evidence arguing for developmental deficits in the maturation of cerebellar
circuits in Spinocerebellar Ataxias. Gunes et al. recapitulate findings of altered excitability in
various elements of motor circuits in ALS and Brunet et al. assemble evidence for cortical
dysfunction as a main driver of ALS pathophysiology. Another set of papers addresses the
circuit mechanism of memory loss in mouse models of dementia. To this end, Vyas et al.
review the complex structural and functional changes of single neurons and neural circuits in
hippocampus of mouse models of AD. Yeung et al. investigate the impact of amyloid-beta 42,
one of the main molecular players in AD, on glutamatergic receptor and transporter expression
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in hippocampus. In a systematic review Rashidi-Ranjbar et al.
revisit evidence for structural and functional impairments of
corticolimbic circuits in late-life depression and dementia.
Furthermore, in a hypothesis paper Janitzky argues for a
compromised function of the locus coereleus (LC)—a brain
region harboring noradrenergic projection neurons—in early
stages of NDs. LC dysfunction results in persistent high
tonic discharge, while the phasic discharge is impaired, which
is hypothesized to diminish putative anti-inflammatory and
neuroprotective effects conveyed by phasic LC firing.
With this Research Topic in Frontiers in Neuroscience,
we aim to provide compelling recent evidence in support
of the hypothesis of altered circuit function as a potent co-
driver of various NDs. This volume contains original research
articles as well as reviews providing an overview of the current
knowledge and technological advances in the mentioned area
of neurodegeneration.
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